EurekAlert! Cancer Research

News Releases

Updates every hour. Last Updated: 27-Jul-2025 22:11 ET (28-Jul-2025 02:11 GMT/UTC)

26-Jun-2025

MD Anderson Research Highlights for June 26, 2025

University of Texas M. D. Anderson Cancer Center
Peer-Reviewed Publication

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back. Promising treatment results for blood cancers, colorectal cancer and brain metastases. Novel insights into early pancreatic cancer cell progression. A new therapeutic target for patients with high blood pressure

26-Jun-2025

‘Chemo brain’ and the aging brain: Researchers examine similarities in search for improved cognition

University of Oklahoma
Peer-Reviewed Publication

While chemotherapy can be lifesaving, it also damages DNA and leads to cognitive issues known as “chemo brain.” These effects resemble the memory and learning problems seen in older adults, prompting University of Oklahoma researchers to investigate this unique overlap of cognitive decline.

Journal: Aging Cell

26-Jun-2025

Study finds that common bacteria in the mouth can help predict the progression of head and neck cancer

Fundação de Amparo à Pesquisa do Estado de São Paulo
Peer-Reviewed Publication

By analyzing patient samples, Brazilian researchers identified the species Fusobacterium nucleatum in nearly 60% of cases, with a higher prevalence in oropharyngeal tumors. This microorganism has also been associated with the development of colorectal cancer.

Journal: Journal of Oral Microbiology
Funder: Fundação de Amparo à Pesquisa do Estado de São Paulo

26-Jun-2025

NRG Oncology appoints new leaders to patient advocate committee and head and neck cancer committee

NRG Oncology
Business Announcement

NRG Oncology (NRG), a National Cancer Institute (NCI) National Clinical Trials Network (NCTN) group focused on improving outcomes for adults with cancer through multi-center clinical research, recently announced that Tambre Leighn was appointed Committee Chair of the NRG Patient Advocate Committee (PAC) and Dr. Chris Holsinger was appointed Surgical Vice Chair of the NRG Head and Neck Cancer (HNC) Committee.

26-Jun-2025

ASTRO updates guideline on radiation therapy for high-grade diffuse glioma, the most common primary brain tumor in adults

American Society for Radiation Oncology
Peer-Reviewed Publication

A new clinical guideline from the American Society for Radiation Oncology (ASTRO) focuses on the use of radiation therapy to treat adult patients with World Health Organization (WHO) grade 4 diffuse gliomas, a category that includes some of the most common and most aggressive primary brain tumors. The guideline, which replaces ASTRO’s 2016 guideline for glioblastoma, is published in Practical Radiation Oncology.

Journal: Practical Radiation Oncology

26-Jun-2025

Researchers decypher structure of a human protease implicated in various diseases

Universitat Autonoma de Barcelona
Peer-Reviewed Publication

A research led by the IBB-UAB has managed to decypher the structure of the human protease SENP5, implicated in neurodegenerative disorders, cardiovascular diseases and the development of cancer. The research, published in Nature Communications, paves the way for therapeutic opportunities with minimal side effects.

Journal: Nature Communications

26-Jun-2025

New gene therapy delivery device could let hospitals create personalized nanomedicines on-demand

Frontiers
Peer-Reviewed Publication

A new gene therapy delivery device could let hospital pharmacies make personalized nanomedicines to order. This democratized approach to precision medicine, as published in Frontiers in Science, could revolutionize how hospitals treat rare diseases, even in low-resource settings.

Journal: Frontiers in Science
Funder: Netherlands Science Agenda, Netherlands Organization for Scientific Research

26-Jun-2025

Saliva analysis could reveal the risk of developing cancer, heart disease or Parkinson’s

University of the Basque Country
Peer-Reviewed Publication

A research team led by the University of the Basque Country (Euskal Herriko Unibertsitatea, EHU) has identified hundreds of molecular markers in saliva that could reveal the risk of a person developing major diseases such as cancer, cardiovascular diseases, diabetes and neurodegenerative diseases. Their results lay the foundation for the development of a powerful, non-invasive tool for early diagnosis and precision medicine

Journal: npj Genomic Medicine

26-Jun-2025

Many older women may have undetected brain tumors

University of Gothenburg
Peer-Reviewed Publication

Tumors of the meninges are more common in older women than previously known. In a study from the University of Gothenburg, 2.7 percent of 70-year-old women in Sweden had such tumors. The researchers emphasize that such findings should be treated with diligence and careful consideration.

Journal: Acta Neurochirurgica

25-Jun-2025

In sub-Saharan Africa, 1 in 6 cancer medications found to be defective

University of Notre Dame
Peer-Reviewed Publication

Serious quality defects were found in a significant number of cancer medications from sub-Saharan Africa, according to new research from the University of Notre Dame.

Journal: The Lancet Global Health
Funder: NIH/National Cancer Institute